Status of immunotherapy: is the time ripe for the secondary prevention of asthma and allergy?

References

• Norman PS. Immunotherapy: past and present. J. Allergy Clin. Immunol.102, 1–10 (1998).
   PubMed Web of Science ®Google Scholar
• Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J. Allergy Clin. Immunol.113, 1025–1034 (2004).
   PubMed Web of Science ®Google Scholar
• Downs SH, Marks GB, Sporik R, Belosouva EG, Car NG, Peat JK. Continued increase in the prevalence of asthma and atopy. Arch. Dis. Child.84, 20–23 (2001).
   PubMed Web of Science ®Google Scholar
• Eigenmann PA. Diagnosis of allergy syndromes: do symptoms always mean allergy? Allergy60(Suppl. 79), 6–9 (2005).
   PubMed Web of Science ®Google Scholar
• von Hertzen L, Haahtela T. Signs of reversing trends in prevalence asthma. Allergy60, 283–292 (2005).
   PubMed Web of Science ®Google Scholar
• Robertson CF, Roberts MF, Kappers JH. Asthma prevalence in Melbourne schoolchildren: have we reached the peak? Med. J. Aust.180, 273–276 (2004).
   PubMed Web of Science ®Google Scholar
• Wang XS, Tan TN, Shek LP et al. The prevalence of asthma and allergies in Singapore; data from two ISAAC surveys seven years apart. Arch. Dis. Child.89, 423–426 (2004).
   PubMed Web of Science ®Google Scholar
• Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet350, 85–90 (1997).
   PubMed Web of Science ®Google Scholar
• Li JT, Lockey RF, Bernstein IL et al. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American Academy of Pediatrics. Joint Task Force on Practice Parameters. Ann. Allergy Asthma Immunol.90, 1–40 (2003).
   Web of Science ®Google Scholar
• Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol.99, 450–453 (1997).
   PubMed Web of Science ®Google Scholar
• Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin. Exp. Allergy31(9), 1392–1397 (2001).
   PubMed Web of Science ®Google Scholar
• Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy57, 306–312 (2002).
   PubMed Web of Science ®Google Scholar
• Moller C, Dreborg S, Ferdousi HA et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J. Allergy Clin. Immunol.109, 251–256 (2002).
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Nüchel-Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy52, 914–920 (1997).
   PubMed Web of Science ®Google Scholar
• Johnstone JE, Dutton A. The value of hyposensitization therapy for branchial asthma in children – a 14-year study. Pediatrics5, 793–802 (1968).
   Google Scholar
• Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med.341, 468–475 (1999).
   PubMed Web of Science ®Google Scholar
• Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy61, 198–201 (2006).
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet2, 1572–1573 (1911).
   Google Scholar
• Kinet JP. A new strategy to counter allergy. N. Engl. J. Med.353, 310–312 (2005).
   PubMed Web of Science ®Google Scholar
• Enrique E, Pineta F, Malek T et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol.116, 1073–1079 (2005).
   PubMed Web of Science ®Google Scholar
• Werfel T, Breuer K, Rueff F et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy61, 202–205 (2006).
   PubMed Web of Science ®Google Scholar
• Cox L. Allergen immunotherapy: immunomodulatory treatment for allergic diseases. Expert Rev. Clin Immunol.2(4), 533–546 (2006).
   Google Scholar
• Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J. Allergy Clin. Immunol.111, 437–448 (2003).
   PubMed Web of Science ®Google Scholar
• Spahn JD, Szefler SJ. Childhood asthma: new insights into management. J. Allergy Clin. Immunol.109, 3–13 (2002).
   PubMed Web of Science ®Google Scholar
• Szefler SJ. Meeting the needs of the modernization act: challenges in developing pediatric therapies. J. Allergy Clin. Immunol.106(Suppl. 3), 115–117 (2000).
   Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med.354, 1985–1997 (2006).
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med.354, 1998–2005 (2006).
   PubMed Web of Science ®Google Scholar
• van den Bemt L, van Knapen L, de Vries MP, Jansen M, Cloosterman S, van Schayck CP. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients. J. Allergy Clin. Immunol.114, 858–862 (2004).
   PubMed Web of Science ®Google Scholar
• Woodcock A, Forster L, Matthews E et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N. Engl. J. Med.349, 225–236 (2003).
   PubMed Web of Science ®Google Scholar
• Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet347, 15–18 (1996).
   PubMed Web of Science ®Google Scholar
• Aas K. Hyposensitization in house dust allergy asthma. A double-blind controlled study with evaluation of the effect on bronchial sensitivity to house dust. Acta Paediatr. Scand.60, 264–268 (1971).
   PubMed Web of Science ®Google Scholar
• Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J. Allergy Clin. Immunol.85, 473–479 (1990).
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ. World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy44(Suppl. 53), 1–42 (1998).
   Google Scholar
• Ostergaard PA, Kaad PH, Kristensen T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy41, 588–593 (1986).
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Marcucci F, Puccinelli P et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy33, 206–210 (2003).
   PubMed Web of Science ®Google Scholar
• Fiocchi A, Pajno G, La Grutta S et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann. Allergy Asthma Immunol.95, 254–258 (2005).
   PubMed Web of Science ®Google Scholar
• Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J. Allergy Clin. Immunol.116, 16–24 (2005).
   PubMed Web of Science ®Google Scholar
• Pajno GB. Allergen immunotherapy in early childhood: between Scylla and Charybdis! Clin. Exp. Allergy35, 551–553 (2005).
   PubMed Web of Science ®Google Scholar
• Arshad SH. Primary prevention of asthma and allergy. J. Allergy Clin. Immunol.116, 3–14 (2005).
   PubMed Web of Science ®Google Scholar